Research Article
Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention
Table 1
MACCEs during 2-year follow-up.
| ||||||||||||||||||||||||||||||||||||||||
MACCE = major adverse cardiovascular and cerebrovascular event, ACS = acute coronary syndrome. |